|
Summary Information: Protara Therapeutics Inc. Common Stock NASDAQ:TARA |
  admin@troach.net |
Our Main Pages Stocks.TRoach.Net TRoach.Org TRoach.Net |
_Description: Protara is committed to identifying and advancing transformative therapies for people with cancer and rare diseases with limited treatment options. Protara's portfolio includes its lead program, TARA-002, an investigational cell-based therapy being developed for the treatment of non-muscle invasive bladder cancer and lymphatic malformations, and IV Choline Chloride, an investigational phospholipid substrate replacement therapy for the treatment of intestinal failure-associated liver disease.
__The following are links to various summary and news pages for __Protara Therapeutics Inc. Common Stock [ TARA ]. __Note: Some Links might not have information for the company. |
|